Literature DB >> 25052396

Veillonella seminalis sp. nov., a novel anaerobic Gram-stain-negative coccus from human clinical samples, and emended description of the genus Veillonella.

Fabien Aujoulat1, Philippe Bouvet2, Estelle Jumas-Bilak3, Hélène Jean-Pierre4, Hélène Marchandin5.   

Abstract

Ten isolates of unknown, Gram-stain-negative, anaerobic cocci were recovered from human clinical samples, mainly from semen. On the basis of their phenotypic features, including morphology, main metabolic end products, gas production, nitrate reduction and decarboxylation of succinate, the strains were identified as members of the genus Veillonella. Multi-locus sequence analysis and corresponding phylogenies were based on 16S rRNA, dnaK and rpoB genes, and on the newly proposed gltA gene. The strains shared high levels of genetic sequence similarity and were related most closely to Veillonella ratti. The strains could not be differentiated from V. ratti on the basis of 16S rRNA gene sequence analysis while gltA, rpoB and dnaK gene sequences showed 85.1, 93.5 and 90.2% similarity with those of the type strain of V. ratti, respectively. Phylogenetic analyses revealed that the isolates formed a robust clade in the V. ratti-Veillonella criceti-Veillonella magna subgroup of the genus Veillonella. As observed for V. criceti, the isolates were able to ferment fructose. In contrast to other members of the genus Veillonella, the 10 strains were not able to metabolize lactate. Cellular fatty acid composition was consistent with that of other species of the genus Veillonella. From these data, the 10 isolates are considered to belong to a novel species in the genus Veillonella, for which the name Veillonella seminalis sp. nov. is proposed. The type strain is ADV 4313.2(T) ( = CIP 107810(T) = LMG 28162(T)). Veillonella strain ACS-216-V-Col6b subjected to whole genome sequencing as part as the Human Microbiome Project is another representative of V. seminalis sp. nov. An emended description of the genus Veillonella is also proposed. IUMS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25052396     DOI: 10.1099/ijs.0.064451-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  7 in total

Review 1.  What's in a Name? New Bacterial Species and Changes to Taxonomic Status from 2012 through 2015.

Authors:  Erik Munson; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

2.  Establishment of a counter-selectable markerless mutagenesis system in Veillonella atypica.

Authors:  Peng Zhou; Xiaoli Li; Fengxia Qi
Journal:  J Microbiol Methods       Date:  2015-03-12       Impact factor: 2.363

3.  Ureteral Stent Microbiota Is Associated with Patient Comorbidities but Not Antibiotic Exposure.

Authors:  Kait F Al; John D Denstedt; Brendan A Daisley; Jennifer Bjazevic; Blayne K Welk; Stephen E Pautler; Gregory B Gloor; Gregor Reid; Hassan Razvi; Jeremy P Burton
Journal:  Cell Rep Med       Date:  2020-09-22

4.  The interaction between Streptococcus spp. and Veillonella tobetsuensis in the early stages of oral biofilm formation.

Authors:  Izumi Mashima; Futoshi Nakazawa
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

5.  Natural Competence Is Common among Clinical Isolates of Veillonella parvula and Is Useful for Genetic Manipulation of This Key Member of the Oral Microbiome.

Authors:  Steven Knapp; Clint Brodal; John Peterson; Fengxia Qi; Jens Kreth; Justin Merritt
Journal:  Front Cell Infect Microbiol       Date:  2017-04-20       Impact factor: 5.293

6.  Host genetic variation and its microbiome interactions within the Human Microbiome Project.

Authors:  Raivo Kolde; Eric A Franzosa; Gholamali Rahnavard; Andrew Brantley Hall; Hera Vlamakis; Christine Stevens; Mark J Daly; Ramnik J Xavier; Curtis Huttenhower
Journal:  Genome Med       Date:  2018-01-29       Impact factor: 11.117

Review 7.  Veillonellae: Beyond Bridging Species in Oral Biofilm Ecology.

Authors:  Peng Zhou; Daniel Manoil; Georgios N Belibasakis; Georgios A Kotsakis
Journal:  Front Oral Health       Date:  2021-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.